Topical Tranexamic Acid in Major Paediatric Spine Deformity Surgery: A Randomized Controlled Trial
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Our study will evaluate the use of topical and intravenous (IV) Tranexamic Acid (TXA) in
spine surgery. The purpose of TXA is to prevent clotting during surgery to reduce blood loss.
When used intravenously, it has been shown to safe, efficacious, and effective in reducing
transfusion requirements and blood loss in spine surgeries. We want to evaluate the effect of
using TXA topically and intravenously to see if it further reduces blood loss in children
undergoing major surgery compared to IV TXA only